TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity

Jing Gu1, Yang-Fan Lv2, Ji-Ying Xia2

  • 1Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing, 400038, PR China.

Cell & Bioscience
|January 24, 2025
PubMed
Abstract

Insights

Tandem C2 domains, nuclear (TC2N) protein promotes lung cancer by maintaining cancer stemness. It activates key signaling pathways by inhibiting DUSP3 phosphatase, revealing a novel mechanism in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tandem C2 domains, nuclear (TC2N) is implicated in lung cancer, potentially through p53 and NF-kappaB pathways.
  • Its precise role in tumorigenesis and cancer stemness remains incompletely understood.

Purpose of the Study:

  • To elucidate the function and mechanism of TC2N in lung cancer development and progression.
  • To investigate the link between TC2N, lung tumorigenesis, and cancer cell stemness.

Main Methods:

  • Utilized TC2N-engineered mice models for assessing knockout effects on normal lung and carcinogenesis.
  • Analyzed lung cancer patient tissues (n=395) for TC2N expression correlation with differentiation.
  • Employed Western blot, immunohistochemistry, cell assays, transcriptomics, proteomics, and co-IP to explore TC2N's mechanisms.

Main Results:

  • TC2N significantly promotes urethane-induced lung tumorigenesis but has minimal effect on normal lung tissue.
  • TC2N overexpression maintains stem-like properties in lung cancer cells.
  • TC2N upregulates EGFR, ERK, STAT3, and FAK1 signaling by inhibiting DUSP3 phosphatase through competitive binding and restricted dephosphorylation.

Conclusions:

  • TC2N plays a critical role in regulating lung cancer stemness and tumorigenesis.
  • TC2N's mechanism involves the dual inhibition of DUSP3 phosphatase, leading to sustained activation of oncogenic signaling pathways.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K